Asthma is the most frequent chronic disease in pediatrics and the increase
in its prevalence is a major public health problem. Diagnosis may be diffic
ult in the young child, symptomatology most often occurring following a vir
al infection. It is important nor to ignore a foreign body in the airways o
r fibrocystic disease and asthma remains, particularly in infants, a diagno
sis of elimination. Misdiagnosis or insufficient treatment of asthma may ri
sk the development of irreversible histological lesions and also could comp
romise pulmonary growth and the child's lung reserve. Spacer devices and ne
bulisers enable inhaled therapy to be administered to very young children.
The value of early diagnosis is to institute appropriate treatment notably
in severe asthma with inhaled corticosteroid therapy, the aim bring to redu
ce remodelling lesions of the airways. The minimal effective dose should be
defined to minimalise side-effects. The treatment of asthma is not restric
ted to pharmacotherapy: attempts should be made to reduce intercurrent vira
l infections, domestic pollution (including smoking) and allergenic concent
rations. However, as for all chronic diseases, the clinician will encounter
poor compliance. The work of education and support of health professionals
is fundamental to the management of asthma.